ArticleBMC medical research methodology2026
Discrete-time neural Markov models.
Article in BMC medical research methodology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Learning Covariate Relations in Disease Progression Models Using Symbolic Neural Networks.CPT: pharmacometrics & systems pharmacology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMarkov models can be used to describe the movement of individuals between states. In medicine, Markov models are used to describe, for example, disease progression and the effects of interventions on such progression. The models can further be used to identify medical risk groups and aid clinicians in clinical decision making. Although accurate individual predictions are crucial for utility on an individual level, modeling of relationships between covariates and transition probabilities includes assumptions regarding the distribution of the data and the functional form of the relationship limiting accurate prediction of individual risks. The purpose of this work was to develop a flexible framework for discrete-time Markov models enabling the use of neural networks to predict individual transition probabilities.
methodsThe framework was implemented in Julia. Both real-world data and simulated data including two possible competing transitions, censoring and non-linear covariate relationships was used for model evaluation. Three models were evalauted: a model excluding covariates, a model including linear mappings between covariates and transition probabilities, and a model using neural networks for predicting individual transition probabilities based on covariates. Models were trained by minimizing the negative likelihood using mini-batching of data for efficient computations of gradients.
resultsThe neural network model outperformed the linear model in predicting individual transition probabilities. Both the negative likelihood and the mean squared error between observed and predicted individual transition probabilities were lower for the neural network model than for the linear model. Individual predicted transition probabilities were more evenly distributed around the line of identity for the neural network model than for the linear model indicating a better predicted functional form of the covariate mapping.
conclusionA simple and flexible framework for development of discrete-time Markov models is described. Including neural networks to map the relationship between covariates and transition probabilities enables increased accuracy in predictions of individual risks and provides a tool to inform clinical interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.